NEW ENGLAND PEDIATRIC ONCOLOGY CONSORTIUM

新英格兰儿科肿瘤学联盟

• 批准号: 2007319
• 负责人: EDWIN N FORMAN
• 金额: $ 13.24万
• 依托单位: RHODE ISLAND HOSPITAL
• 依托单位国家: 美国
• 财政年份: 1981
• 资助国家: 美国
• 起止时间: 1981-01-01 至 2000-12-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/2007319
• 关键词: 6 thiopurine; Ewing's tumor; Hodgkin's disease; Wilms' tumor; XomaZyme; acivicin; acute leukemia; acute lymphocytic leukemia; acute myelogenous leukemia; adolescence (12-20); antineoplastics; asparaginase; astrocytoma; biological response modifiers; bone marrow transplantation; brain neoplasms; cancer registry /resource; cancer risk; central nervous system neoplasms; child (0-11); chronic myelogenous leukemia; cis platinum compound; clinical research; clinical trial phase I; colony stimulating factor; combination cancer therapy; combination chemotherapy; cooperative study; cyclophosphamide; cyclosporines; cytosine arabinoside; daunorubicin; deferoxamine; deoxycoformycin; doxorubicin; drug screening /evaluation; enalapril; ependymoma; etoposide; fazarabine; fluorouracil; germ cell neoplasms; glioma; hepatoblastoma; hepatocellular carcinoma; human genetic material tag; human immunodeficiency virus 1; human subject; human therapy evaluation; human tissue; ifosfamide; interferons; interleukin 2; medulloblastoma; melphalan; metastasis; methotrexate; mitoxantrone; molecular oncology; neoplasm /cancer chemotherapy; neoplasm /cancer classification /staging; neoplasm /cancer epidemiology; neoplasm /cancer genetics; neoplasm /cancer immunology; neoplasm /cancer immunotherapy; neoplasm /cancer pharmacology; neoplasm /cancer radiation therapy; neoplasm /cancer relapse /recurrence; neoplasm /cancer surgery; neuroblastoma; nonHodgkin's lymphoma; osteosarcoma; paclitaxel; pediatric pharmacology; podophyllin; prednisone; retinoate; rhabdomyosarcoma; tissue resource /registry; topotecan; trimetrexate; vincristine

The specific aims of the New England Pediatric Oncology Consortium (NEPOC) are: Development and enhanced productivity of a consortium of regional pediatric cancer centers (Brown University/Rhode Island Hospital; Dartmouth University/Dartmouth-Hitchcock Medical Center; Harvard University/Massachusetts General Hospital; SUNY at Stony Brook/Children's Medical Center at Stony Brook; University of Vermont/Medical Center Hospital-Vermont Regional Cancer Center) for the purposes of: A. Contributing to the understanding and treatment of children and adolescents with malignancies through: 1. Input into national cooperative studies through membership in the Pediatric Oncology Group (POG): a. Patient accrual: Achieve significant number and quality of patient entries on protocols; b. Study development and evaluation: Assist in the development of new protocols through committee memberships, institutional reviews of proposed protocol designs, analysis of study results, and proposal of new protocols for POG implementation based on NEPOC studies; c. Administration: Accept responsibilities for POG administrative functions. 2. Cooperative efforts within NEPOC (New England Pediatric Oncology Consortium) in studies of joint interest in the areas of childhood malignancies, particularly toward developing potential pilot studies for POG. B. Enhancement of the care of children and adolescents with cancer in the geographical areas served by the member institutions through: 1. Assuring comprehensive and modern management of children and adolescents with malignancies as a benefit of membership in POG; 2. Sharing staff expertise and investigative facilities at each of the member institutions; 3. Joint efforts in promotion of education of the local community in the area of cancer in children and adolescents. Through a centralized administration, this Consortium integrates the activities and resources (staff, facilities, patients) at each institution into a single program aimed at achieving these goals.

新英格兰儿科肿瘤学联盟的具体目的 （NEPOC）是：一个财团的发展和提高生产率 区域小儿癌症中心（布朗大学/罗德岛大学 医院;达特茅斯大学/达特茅斯 - 希区柯克医学中心； 哈佛大学/马萨诸塞州综合医院；纽约州纽约州 Stony Brook的Brook/儿童医疗中心；大学 佛蒙特州/医疗中心医院 - 弗里蒙特地区癌症中心） 目的： A.为儿童的理解和治疗做出贡献 患有恶性肿瘤的青少年： 1。通过成员参与国家合作研究的投入 小儿肿瘤学组（POG）： 一个。应计患者：获得大量患者的数量和质量 协议的条目； b。研究开发和评估：协助开发新的 通过委员会成员资格的协议，机构审查 提议的协议设计，研究结果分析和新建议 基于NEPOC研究的POG实施方案； c。管理：接受POG管理的责任 功能。 2. NEPOC中的合作努力（新英格兰儿科肿瘤学 财团）在研究童年领域的共同兴趣研究中 恶性肿瘤，特别是为了开发潜在的试点研究 pog。 B.增强对儿童和青少年癌症的护理 会员机构为： 1。确保对儿童的全面和现代管理以及 有恶性肿瘤的青少年是POG成员的好处； 2。分享每个人的员工专业知识和调查设施 会员机构； 3。促进当地社区教育的共同努力 儿童和青少年的癌症区域。 通过集中管理，该财团整合了 每个活动的活动和资源（工作人员，设施，患者） 旨在实现这些目标的单一计划的机构。